🇺🇸 FDA
Pipeline program

LC-1000

SF11263

Phase 3 other completed

Quick answer

LC-1000 for Coronary Artery Disease is a Phase 3 program (other) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Coronary Artery Disease
Phase
Phase 3
Modality
other
Status
completed

Clinical trials